期刊文献+

140例Graves’病患者血清HA、LN、PCⅢ、IV.C含量的临床分析 被引量:5

Clinical analysis of serum level of hyaluronic acid,laminin,type Ⅲ procollagen peptide and type IV collagen in 140 Graves' disease patients
下载PDF
导出
摘要 目的 :应用血清中的HA、LN、PCⅢ、IV .C含量 ,来判断甲状腺功能亢进对肝脏功能的影响。方法 :采用放射免疫法测定 14 0例Graves’病患者和 33例健康体检者的血清HA、LN、PCⅢ、IV .C含量。Graves’病患者分为初诊未用ATD组 ( 5 9例 )和曾用ATD组 ( 81例 )。结果 :血清HA含量未用ATD组 (均数±标准差 119.4 3± 10 7.0 8μg/L)明显高于对照组 ( 78.30±5 8.4 4 μg/L) ,P <0 .0 5 ,而曾用ATD组 ( 10 8.4 9± 6 6 .94 μg/L)与对照组之间无显著性差异 ;血清LN、PCⅢ、IV .C含量在所有的病人均显著高于对照组 ,P <0 .0 0 1,未用ATD组分别为 ( 2 0 3.18± 98.5 5 )、( 2 0 9.0 6± 10 8.6 2 )、( 117.79± 6 3.39) μg/L ,曾用ATD组分别为 ( 190 .0 3± 79.37)、( 172 .36± 10 4 .4 5 )、( 119.0 2± 4 7.38) μg/L ,对照组分别为 ( 130 .88± 15 .12 )、( 74 .5 9± 2 1.87)、( 6 4 .5 6± 2 7.6 4 ) μg/l。 结论 :Graves’病患者无论是否接受过ATD治疗 ,血清LN、PCⅢ、IV .C增高 ;HA在初诊病人升高 ,而接受过ATD治疗的病人正常 ,也许与ATD的免疫调节有关。 Objective:To observe the effect of hepatic function in hyperthyroidism patients with serum levels of hyaluronic acid(HA),laminin,type Ⅲ procollagen peptide and type IV collagen.Methods:We measured them in 140 patients with Graves' disease and 33 healthy subjects by radioimmunoassay.Graves' disease patients were divided into two groups,one including 59 patients with primary diagnosis and not treated with antithyroid drug(ATD),the other group including 81 patients were once treated with ATD.Results:HA concentration was significantly higher( P <0.05) in the patients without ATD therapy(mean+SD 119.43±107.08 microgram/l) than in the healthy control subjects(78.30±58.44microgram/l).But in the patients with ATD therapy serum level of HA was 108.49±66.94 microgram/l.Compared with the control,there was no significant diffrence.Serum levels of laminin,type Ⅲ procollagen peptide and type IV collagen in all patients(in the patients without ATD therapy were 203.18±98.55,209.06±108.62,117.79±63.39 microgram/l respectively,in the patients with ATD therapy were 190.03±79.37,172.36±104.45,119.02±47.38 microgram/l respectively) were significantly higher ( P <0.001) than in the control(130.88±15.12,74.59±21.87,64.56±27.64 microgram/l respectively).Conclusion:The results demonstrate that serum levels of lammin,type Ⅲ procollagen peptide and type IV collagen are elevated in hyperthyroidism state,while HA concentration in primary diagnosis patients is elevated,but in the patients treated with ATD it is normal,which may relate with the immunoregulating action of ATD.
出处 《重庆医科大学学报》 CAS CSCD 2004年第3期381-382,388,共3页 Journal of Chongqing Medical University
关键词 Graves’病 透明质酸 层粘蛋白 Ⅲ型前胶原肽 IV型胶原 Graves' disease Hyaluronic acid Laminin Type Ⅲ procollagen peptide Type IV collagen
  • 相关文献

参考文献10

  • 1马德林,徐燕红,杨吉生.甲亢患者血清HA、C- Ⅳ、CG的临床意义[J].标记免疫分析与临床,2001,8(2):78-79. 被引量:6
  • 2曾民德 萧树东.肝脏与内分泌[M].北京:人民卫生出版社,1997.96.
  • 3Leslie J.DeGroot,P.Reed Larsen,Samuel Refetoff,et al.The Thyroid and its Diseases[M].Copyright 1984 by John Wiley &amp; Sons,Inc,376-377.
  • 4Ohtsuka Y,Yamamoto K,GotoY,et al.Localized myxedema,associated with increased serum hyaluronic acid,and response to steroid pulse therapy[J].Intern Med,1995;34(5):424-429.
  • 5Inui T,Ochi Y,Chen W,et al.Increased serum concentration of type Ⅳ collagen peptide and type Ⅲ collagen peptide in hyperthyroidism [ J ].Clin Chim Acta,1992; 204 (3):181 -186.
  • 6Shima T,Yano Y,Goto H,et al.Increased concentrations of type Ⅳ(7S)collagen in sera of hyperthyroid patients with Graves' disease[ J ].Clin Chem,1992; 38 (9):1843-1846.
  • 7杨军,林晓北.初发甲亢患者血清HA、GPT和β_2-MG水平测定[J].标记免疫分析与临床,1998,5(3):165-167. 被引量:2
  • 8徐燕红,杨吉生,马德林,徐增秀,彭晓燕.甲亢初诊与甲亢经过治疗后血清HA、C-Ⅳ、ALT的结果分析[J].放射免疫学杂志,2001,14(2):102-103. 被引量:1
  • 9周志芬.甲亢患者C-IV、LN和HA测定分析[J].上海医学检验杂志,1997,12(2):117-117.
  • 10谢蓉星,陈文韩.甲亢患者血清HA、LN、PCⅢ及Ⅳ.C RIA[J].放射免疫学杂志,2001,14(4):224-225. 被引量:3

二级参考文献10

共引文献24

同被引文献33

引证文献5

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部